Evidence map›Paper›PMID 24916661›Full record

ArticleGenome biology and evolution2014

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.

Nicholas J Croucher, Claire Chewapreecha, William P Hanage, Simon R Harris, Lesley McGee, Mark van der Linden, Jae-Hoon Song, Kwan Soo Ko, Herminia de Lencastre, Claudia Turner and 7 more

Abstract read
In one paragraph

Article in Genome biology and evolution, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed.

  1. Review
  2. Artificial Intelligence-Guided Phenotypic Drug Repurposing Against Streptococcus pneumoniae.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Persistence of vaccine-induced serotype-related pathology in invasive pneumococcal disease in children. Community of Madrid, 2007-2024.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Ultrastructural, metabolic and genetic characteristics of determinants facilitating the acquisition of macrolide resistance by Streptococcus pneumoniae.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Nicholas J CroucherCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, MassachusettsPathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.
Claire ChewapreechaPathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.
William P HanageCenter for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.
Simon R HarrisPathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.
Lesley McGeeRespiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
Mark van der LindenInstitute for Medical Microbiology, National Reference Center for Streptococci, University Hospital, RWTH Aachen, Aachen, Germany.
Jae-Hoon SongSamsung Medical Centre, Sungkyunkwan University School of Medicine and Asia Pacific Foundation for Infectious Disease, Seoul, South Korea.
Kwan Soo KoDepartment of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea.
Herminia de LencastreLaboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, PortugalLaboratory of Microbiology, The Rockefeller University, New York, New York.
Claudia TurnerShoklo Malaria Research Unit, Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, ThailandMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, ThailandCentre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, United Kingdom.
Fan YangInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Raquel Sá-LeãoLaboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal.
Bernard BeallRespiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
Keith P KlugmanHubert Department of Global Health, Rollins School of Public Health and Division of Infectious Diseases, School of Medicine, Emory UniversityCentre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases, Gauteng, South Africa.
Julian ParkhillPathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom.
Paul TurnerShoklo Malaria Research Unit, Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Mae Sot, ThailandMahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, ThailandCentre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, United Kingdom.
Stephen D BentleyPathogen Genomics, The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United KingdomDepartment of Medicine, University of Cambridge, Addenbrooke's Hospital, United Kingdom sdb@sanger.ac.uk.

Funding

Wellcome TrustWellcome Trust 083735/Z/07/ZWellcome Trust 098051
6 · The paper itself

Abstract

The multidrug-resistant Streptococcus pneumoniae Taiwan(19F)-14, or PMEN14, clone was first observed with a 19F serotype, which is targeted by the heptavalent polysaccharide conjugate vaccine (PCV7). However, "vaccine escape" PMEN14 isolates with a 19A serotype became an increasingly important cause of disease post-PCV7. Whole genome sequencing was used to characterize the recent evolution of 173 pneumococci of, or related to, PMEN14. This suggested that PMEN14 is a single lineage that originated in the late 1980s in parallel with the acquisition of multiple resistances by close relatives. One of the four detected serotype switches to 19A generated representatives of the sequence type (ST) 320 isolates that have been highly successful post-PCV7. A second produced an ST236 19A genotype with reduced resistance to β-lactams owing to alteration of pbp1a and pbp2x sequences through the same recombination that caused the change in serotype. A third, which generated a mosaic capsule biosynthesis locus, resulted in serotype 19A ST271 isolates. The rapid diversification through homologous recombination seen in the global collection was similarly observed in the absence of vaccination in a set of isolates from the Maela refugee camp in Thailand, a collection that also allowed variation to be observed within carriage through longitudinal sampling. This suggests that some pneumococcal genotypes generate a pool of standing variation that is sufficiently extensive to result in "soft" selective sweeps: The emergence of multiple mutants in parallel upon a change in selection pressure, such as vaccine introduction. The subsequent competition between these mutants makes this phenomenon difficult to detect without deep sampling of individual lineages.

Indexed as

Evolution, MolecularChromosome MappingDrug Resistance, MultipleHumansPhylogenyPneumococcal VaccinesRecombination, GeneticSelection, GeneticStreptococcus pneumoniaePneumococcal Vaccinesantibiotic resistancebacterial evolutionphylogenomicsrecombinationselective sweepsvaccine escape

Identifiers

PMID24916661
PMCPMC4122920

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.